يحاول ذهب - حر

ENGENDERING INCLUSIVITY & DIVERSITY IN LIFE SCIENCES

March 2024

|

BioSpectrum Asia

Globally, women constitute 46 per cent of the workforce in the public sector, whereas in the private sector, they represent 33 per cent. The public sector maintains a higher representation of women as employees compared to the private sector as per data from the World Bank.

- Ayesha Siddiqui

ENGENDERING INCLUSIVITY & DIVERSITY IN LIFE SCIENCES

While men outnumber women in the private sector across 130 countries, the trend is shifting in the public sector, where women outnumber men in 55 nations. This data sheds light on the increasing presence of women in high- and upper-middle-income countries' public sectors, highlighting a significant shift in workforce demographics.

In the realm of the public sector in life sciences, remarkable women are at the helm, steering initiatives and shaping policies that impact millions. From regulatory bodies to research institutions, these leaders exemplify excellence and resilience.

There's Dr Choong May Ling, who serves as the chief executive for Singapore's health regulatory body, or China's leading epidemiologist Prof. Li Lanjuan, who was instrumental in the country's fight against COVID-19. There's Dr Diana Siew, who is taking New Zealand's medtech sector to greater heights, along with many other inspiring women. These women, among many others, inspire the next generation of leaders and pave the way for inclusive and equitable practices in the life sciences sector.

We are celebrating International Women's Day on March 8, by spotlighting women's roles and challenges in life sciences, spanning leadership, clinical trials participation and pay parity issues. The story is divided into three parts. The first part highlights the remarkable achievements of women leading the public sector organisations in life sciences in APAC. In the second section, we will be discussing the persistent issue of pay parity in the sector, while the final section tackles issues related to women in clinical trials. Let's delve deeper. 

SINGAPORE

Leader par excellence

Dr Choong May Ling, Mimi, CEO, Health Sciences Authority (HSA)

المزيد من القصص من BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

WHO and the European Commission expand partnership to combat AMR

The World Health Organization (WHO) and the European Commission's Health Emergency Preparedness Authority (HERA) have signed a €3.5 million agreement to expand their partnership to combat antimicrobial resistance (AMR) under the EU4Health programme.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

Reshaping Asia's Healthcare with mRNA Innovation

The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the biotechnology landscape across Asia and beyond. What emerged during this period was not just a breakthrough moment for mRNA, but the early foundation of a broader transformation that is still unfolding.

time to read

2 mins

BioSpectrum Asia Jan 2026

BioSpectrum Asia

BioSpectrum Asia

PRISM BioLab partners with Talus Bioscience for AI-based drug discovery

Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel inhibitors of transcription factor (TF) and protein-protein interaction (PPI) targets.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

Ferronova raises $6 M to advance imageguided cancer surgery

Australian startup Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence following surgery.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

BioSpectrum Asia

PAHO launches roadmap to improve blood pressure control

The Pan American Health Organization (PAHO) has launched the new HEARTS Quality Framework, a practical guide published in The Lancet Regional Health - Americas, which countries can immediately use to enhance hypertension and cardiovascular risk management, prevent heart attacks and strokes, and deliver better care through primary health care within their communities.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

BioSpectrum Asia

UK and Singapore launch new regulatory innovation corridor to fast-track health technologies

As part of this first-of-its-kind partnership between the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and Singapore's Health Sciences Authority (HSA), companies will have a coordinated fast track pathway to engage both regulators at the same time.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

Zydus Lifesciences partners with Myriad Genetics to launch cancer-risk assessment diagnostic tests in India.

India-based Zydus Lifesciences has signed an agreement with US-based Myriad Genetics, a leader in molecular diagnostic testing and precision medicine.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

BioSpectrum Asia

Korea steps up pandemic response with $18.9 M investment in CEPI

The Republic of Korea has announced new $18.9 million support to bolster national and global efforts to protect against the next deadly pandemic and boost international health security.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

BioSpectrum Asia

Belgium and WHO sign new agreement to boost global health accessibility

The World Health Organization (WHO) has announced a new €8 million, four-year contribution from the Government of Belgium to accelerate global equitable access to essential health products and technologies.

time to read

1 min

BioSpectrum Asia Jan 2026

BioSpectrum Asia

Pharmacopoeia Commission of India inks 3 MoUs with Nagaland

The Pharmacopoeia Commission of India (IPC), an autonomous institute under the Ministry of Health and Family Welfare, Government of India, has signed three Memorandums of Understanding (MoUs) with Nagaland Medical Council, Nagaland State Drug Control Administration (NSDCA), Department of Health and Family Welfare, Nagaland and State Pharmacy Council, Government of Nagaland, a northeastern state of India.

time to read

1 min

BioSpectrum Asia Jan 2026

Listen

Translate

Share

-
+

Change font size